{"transactions":[{"id":673639,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":19044,"kind":"person","name":"RIOUX PATRICE","position":1,"cik":"0001241033","reported_name":"RIOUX PATRICE","relationship":{"other":true,"other_text":"Acting Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-08-27T23:29:11.000Z","date":"2026-08-26","kind":"exercise","planned":true,"acquired":true,"shares":1380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 27, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 15, 2016, the reporting person was granted stock options to purchase up to 1,400 shares of common stock vested: 238 shares on January 15, 2017; 224 shares on February 15, 2017; 238 shares on March 15, 2017; 224 shares on April 15, 2017; 238 shares on May 15, 2017; and 238 shares on June 15, 2017."}],"balance_after":0,"derivative":{"exercise_price":0.005,"expiration_date":"2026-12-14","underlying":"Common Stock","underlying_shares":1380},"source":{"system":"sec-edgar","filing":"0001437749-26-029121","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241033/000143774926029121/rdgdoc.xml","form_type":"4"}},{"id":673638,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":19044,"kind":"person","name":"RIOUX PATRICE","position":1,"cik":"0001241033","reported_name":"RIOUX PATRICE","relationship":{"other":true,"other_text":"Acting Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-27T23:29:11.000Z","date":"2026-08-26","kind":"sale","planned":true,"acquired":false,"shares":1,"price":111.26,"value":111.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 27, 2026."}],"balance_after":5065,"source":{"system":"sec-edgar","filing":"0001437749-26-029121","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241033/000143774926029121/rdgdoc.xml","form_type":"4"}},{"id":673637,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":19044,"kind":"person","name":"RIOUX PATRICE","position":1,"cik":"0001241033","reported_name":"RIOUX PATRICE","relationship":{"other":true,"other_text":"Acting Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-27T23:29:11.000Z","date":"2026-08-26","kind":"exercise","planned":true,"acquired":true,"shares":1380,"price":0.005,"value":6.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 27, 2026."}],"balance_after":5066,"source":{"system":"sec-edgar","filing":"0001437749-26-029121","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241033/000143774926029121/rdgdoc.xml","form_type":"4"}},{"id":950670,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":19044,"kind":"person","name":"RIOUX PATRICE","position":1,"cik":"0001241033","reported_name":"RIOUX PATRICE","relationship":{"other":true,"other_text":"Acting Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-01-05T20:45:36.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock Options vesting commenced on January 1, 2026 as follows: 1/12th of the 2,000 options vest on January 31, 2026 and each subsequent month-end thereafter."}],"balance_after":2000,"derivative":{"exercise_price":65.3,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001437749-26-000304","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241033/000143774926000304/rdgdoc.xml","form_type":"4"}},{"id":1318444,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":19044,"kind":"person","name":"RIOUX PATRICE","position":1,"cik":"0001241033","reported_name":"RIOUX PATRICE","relationship":{"other":true,"other_text":"Acting Chief Medical Officer"}}],"security":"Stock Options","published_at":"2025-01-02T23:16:28.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock Options vesting commenced on January 1, 2025 as follows: 1/12th of 2,000 options on January 31, 2025 and each subsequent month-end thereafter."}],"balance_after":2000,"derivative":{"exercise_price":22,"expiration_date":"2034-12-31","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001437749-25-000098","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241033/000143774925000098/rdgdoc.xml","form_type":"4"}},{"id":1691540,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":19044,"kind":"person","name":"RIOUX PATRICE","position":1,"cik":"0001241033","reported_name":"RIOUX PATRICE","relationship":{"other":true,"other_text":"Acting Chief Medical Officer"}}],"security":"Stock Options","published_at":"2024-01-04T00:33:18.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock Options vesting commenced on January 1, 2024 as follows: 833 on January 31, 2024 and each subsequent month-end thereafter."}],"balance_after":10000,"derivative":{"exercise_price":0.3402,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-000479","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241033/000143774924000479/rdgdoc.xml","form_type":"4"}},{"id":2072330,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":19044,"kind":"person","name":"RIOUX PATRICE","position":1,"cik":"0001241033","reported_name":"RIOUX PATRICE","relationship":{"other":true,"other_text":"Acting Chief Medical Officer"}}],"security":"Stock Options","published_at":"2023-01-03T20:58:34.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock Options vesting commenced on January 1, 2023 as follows: 833 on January 31, 2023 and each subsequent month-end thereafter."}],"balance_after":10000,"derivative":{"exercise_price":2.37,"expiration_date":"2031-12-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-23-000159","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241033/000143774923000159/rdgdoc.xml","form_type":"4"}},{"id":2448125,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":19044,"kind":"person","name":"RIOUX PATRICE","position":1,"cik":"0001241033","reported_name":"RIOUX PATRICE","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Acting Chief Medical Officer"}}],"security":"Stock Options","published_at":"2022-01-04T18:47:03.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock Options vesting commenced on January 1, 2022 as follows: 833 on January 31, 2022 and each subsequent month-end thereafter."}],"balance_after":10000,"derivative":{"exercise_price":3.21,"expiration_date":"2031-12-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001654954-22-000123","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241033/000165495422000123/section16.xml","form_type":"4"}},{"id":2919881,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":19044,"kind":"person","name":"RIOUX PATRICE","position":1,"cik":"0001241033","reported_name":"RIOUX PATRICE","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Acting Chief Medical Officer"}}],"security":"Stock options","published_at":"2021-01-05T22:28:11.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock Options vesting commenced on January 1, 2021 as follows: 833 on January 31, 2021 and each subsequent month-end thereafter."}],"balance_after":10000,"derivative":{"exercise_price":6.12,"expiration_date":"2030-12-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001654954-21-000146","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241033/000165495421000146/section16.xml","form_type":"4"}},{"id":3259113,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":19044,"kind":"person","name":"RIOUX PATRICE","position":1,"cik":"0001241033","reported_name":"RIOUX PATRICE","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Acting Chief Medical Officer"}}],"security":"Stock Options","published_at":"2020-02-21T02:05:12.000Z","date":"2020-01-30","kind":"grant","acquired":true,"shares":6125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock Options vesting commenced on January 1, 2020 as follows: 510 on January 31, 2020 and each subsequent month-end thereafter."}],"balance_after":6125,"derivative":{"exercise_price":16.8,"expiration_date":"2030-01-30","underlying":"Common Stock","underlying_shares":6125},"source":{"system":"sec-edgar","filing":"0001654954-20-001798","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241033/000165495420001798/section16.xml","form_type":"4"}},{"id":3358581,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":19044,"kind":"person","name":"RIOUX PATRICE","position":1,"cik":"0001241033","reported_name":"RIOUX PATRICE","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Acting Chief Medical Officer"}}],"security":"Stock options","published_at":"2019-11-27T00:40:39.000Z","date":"2019-11-26","kind":"exercise","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Original stock options to purchase up to 7,000 shares of common stock vested: 1,190 shares on January 15, 2017; 1,120 shares on February 15, 2017; 1,190 shares on March 15, 2017; 1,120 shares on  April 15, 2017; 1,190 shares on May 15, 2017; and 1,190 shares on June 15, 2017."}],"balance_after":6900,"derivative":{"exercise_price":0.001,"expiration_date":"2026-12-14","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001654954-19-013406","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1241033/000165495419013406/section16.xml","form_type":"4"}},{"id":3358580,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":19044,"kind":"person","name":"RIOUX PATRICE","position":1,"cik":"0001241033","reported_name":"RIOUX PATRICE","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Acting Chief Medical Officer"}}],"security":"Stock options","published_at":"2019-11-27T00:40:39.000Z","date":"2019-11-26","kind":"exercise","acquired":false,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Original stock options to purchase up to 32,004 shares of common stock vested 12,000 shares upon grant date of January 1, 2018 and 1,667 shares on the first of each month thereafter."}],"balance_after":13671,"derivative":{"exercise_price":6,"expiration_date":"2027-12-31","underlying":"Common Stock","underlying_shares":18333},"source":{"system":"sec-edgar","filing":"0001654954-19-013406","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241033/000165495419013406/section16.xml","form_type":"4"}},{"id":3358579,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":19044,"kind":"person","name":"RIOUX PATRICE","position":1,"cik":"0001241033","reported_name":"RIOUX PATRICE","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Acting Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T00:40:39.000Z","date":"2019-11-26","kind":"exercise","acquired":true,"shares":100,"price":0.001,"value":0.1,"ownership":{"direct":true},"balance_after":18433,"source":{"system":"sec-edgar","filing":"0001654954-19-013406","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241033/000165495419013406/section16.xml","form_type":"4"}},{"id":3358578,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":19044,"kind":"person","name":"RIOUX PATRICE","position":1,"cik":"0001241033","reported_name":"RIOUX PATRICE","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Acting Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-27T00:40:39.000Z","date":"2019-11-26","kind":"exercise","acquired":true,"shares":18333,"price":6,"value":109998.0,"ownership":{"direct":true},"balance_after":18333,"source":{"system":"sec-edgar","filing":"0001654954-19-013406","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241033/000165495419013406/section16.xml","form_type":"4"}},{"id":3686588,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":19044,"kind":"person","name":"RIOUX PATRICE","position":1,"cik":"0001241033","reported_name":"RIOUX PATRICE","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Acting Chief Medical Officer"}}],"security":"Stock option","published_at":"2019-01-26T01:58:58.000Z","date":"2018-12-30","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest and become exercisable according to the following schedule: 1,667 shares vest on January 31, 2019 and the last day of each subsequent month thereafter."}],"balance_after":20000,"derivative":{"exercise_price":6,"exercise_date":"2019-01-31","expiration_date":"2028-12-30","underlying":"Common stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-19-000796","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241033/000165495419000796/section16.xml","form_type":"4"}}]}